NCT01861847 - 7-Keto DHEA for the Treatment of PTSD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

PTSD

Interventions

DRUG

7-Keto Dehydroepiandrosterone

7-Keto Dehydroepiandrosterone, 100 mg capsules given orally twice daily for 4 weeks in one of the two intervention phases, dependent on randomization assignment.

DRUG

Placebo

Placebo, 100 mg capsules given orally twice daily for 4 weeks in one of the two intervention phases, dependent on randomization assignment.

Trial Locations (1)

33744

Bay Pines VA Healthcare System, Bay Pines